Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 4/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octyl Acetate SCHEMBL22408892 | 1.00 | MEN1 (0.58) | MEN1THRBHTTKMT2AMAPT | |
| Heptylacetate SCHEMBL22408898 | 1.00 | MEN1 (0.58) | MEN1THRBHTTKMT2AMAPT | |
| Hexyl Acetate SCHEMBL19064974 | 0.98 | MEN1 (0.61) | MEN1THRBHTTKMT2AMAPT | |
| Acetic Acid Pentyl Ester SCHEMBL19064948 | 0.98 | ALDH1A1 (0.59) | MEN1THRBHTTKMT2AMAPT | |
| Triethylene Glycol SCHEMBL19064942 | 0.97 | MEN1 (0.58) | MEN1THRBHTTKMT2AMAPT | |
| Hexyl Acetate SCHEMBL9694598 | 0.95 | ALDH1A1 (0.59) | MEN1THRBHTTKMT2AMAPT | |
| Acetic Acid Pentyl Ester SCHEMBL8810307 | 0.93 | TSHR (0.60) | MEN1THRBHTTKMT2AMAPT | |
| Acetic Acid Pentyl Ester SCHEMBL27558530 | 0.93 | ALDH1A1 (0.61) | MEN1THRBHTTKMT2AMAPT | |
| Heptylacetate SCHEMBL22444980 | 0.93 | ALDH1A1 (0.61) | MEN1THRBHTTKMT2AMAPT | |
| Dodecylacetate SCHEMBL599480 | 0.93 | ALDH1A1 (0.61) | MEN1THRBHTTKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0934078-B1 | PERMEATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS, DEVICES, AND METHODS | ALZA CORP (US) | 2002-12-18 | — | — | EP | claimed |
| US-6004578-A | FOR ENHANCING THE PERCUTANEOUS ABSORPTION OF DRUGS WHEN ADMINISTERED TO A BODY SURFACE OR MEMBRANE | ALZA CORPORATION (US) | 1999-12-21 | — | — | US | claimed |
| EP-0934078-A2 | PERMEATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS, DEVICES, AND METHODS | ALZA CORPORATION (US) | 1999-08-11 | — | — | EP | claimed |
| WO-1998017315-A2 | PERMEATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS, DEVICES, AND METHODS | ALZA CORPORATION (US) | 1998-04-30 | — | — | WO | claimed |
| EP-0934078-B1 | PERMEATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS, DEVICES, AND METHODS | ALZA CORP (US) | 2002-12-18 | — | — | EP | disclosed |
| US-6004578-A | FOR ENHANCING THE PERCUTANEOUS ABSORPTION OF DRUGS WHEN ADMINISTERED TO A BODY SURFACE OR MEMBRANE | ALZA CORPORATION (US) | 1999-12-21 | — | — | US | disclosed |
| EP-0934078-A2 | PERMEATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS, DEVICES, AND METHODS | ALZA CORPORATION (US) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998017315-A2 | PERMEATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS, DEVICES, AND METHODS | ALZA CORPORATION (US) | 1998-04-30 | — | — | WO | disclosed |